Navigation Links
Weizmann Institute scientists develop a general 'control switch' for protein activity

lled a “library” in scientific language) with the amino acid segment inserted in different places. In the second stage, the engineered proteins are screened to identify the ones that respond to the drug in a desired manner. The researchers have discovered that in some of the engineered proteins the drug increased the activity level, while in others this activity was reduced. Says Prof. Liscovitch: “We were surprised by the effectiveness of the method – it turns out that a small set of engineered proteins is needed to find the ones that respond to the drug. With their greater resources, biotechnology companies will be able to create much larger sets of engineered proteins in order to find one that best meets their needs.”

The method developed by the Weizmann Institute scientists is ready for immediate use, both in basic biomedical research and in the pharmaceutical industry, in the search for proteins that can serve as targets for new drugs. Beyond offering a potent tool that can be applied to any protein, the method has an important advantage compared with other techniques: It allows the total and precise control over the activity of an engineered protein. Such activity can be brought to a desired level or returned to its natural level, at specific locations in the body and at specific times – all this by giving exact and well-timed doses of the same simple drug.

In addition, the method could be used one day in gene therapy. It may be possible to replace damaged proteins that cause severe diseases with genetically engineered proteins, and to control these proteins’ activity levels in a precise manner by giving appropriate doses of the drug. Another potential future application is in agricultural genetic engineering. The method might make it possible, for example, to create genetically engineered plants in which the precise timing of fruit ripening would be controlled using a substance that increases the activity of proteins responsible for rip
'"/>

Source:American Committee for the Weizmann Institute of Science


Page: 1 2 3

Related biology news :

1. Weizmann Institute scientists develop a new approach for directing treatment to metastasized prostate cancer in the bones.
2. Weizmann Institute suggests that immune cells help to maintain cognition and brain cell renewal
3. Weizmann Institute scientists discover a molecular security mechanism for keeping mutations in check
4. Affymetrix and the Karolinska Institutet Announce Translational Medicine Strategic Alliance
5. BioMed Central welcomes the new National Institutes of Health public access policy
6. Institute for Systems Biology Symposium Addresses Need for Better Computational Tools
7. Virginia Tech, Nanjing Institute researchers discover half-billion year-old fossils
8. UC San Diego partners with Venter Institute to build marine microbial genomics cyberinfrastructure
9. Virginia Bioinformatics Institutes launches microbial database
10. Latest advances in DNA sequencing highlighted at DOE Joint Genome Institute User Meeting
11. UCLA AIDS Institute researchers find a peptide that encourages HIV infection

Post Your Comments:
(Date:11/26/2009)...eir impressive antlers, red deer have been caught ...,s antlers are much more than decorative. They are...lling. John Currey, from The University of York, U... of bone for over half a century and has become fa...rough a long-standing collaboration with Tomas Lan...
(Date:11/26/2009)...g, 27 November 2009 What are the bare essentials ... produce a cell that can survive on its own? Can w...derstand how an entire organism functions as a sys...entists in a partnership between the European Mole...many, and the Centre de Regulacio Genmica (CRG) in...
(Date:11/25/2009)...Bacteria don,t have easy lives. In addition to mam...have natural enemies called bacteriophages, viruse...ays. , Still, bacteria and another class of mic...treme environments such as deep-sea volcanic vents...y have a built-in defense system that helps protec...
Breaking Biology News(10 mins):Tough yet stiff deer antler is materials scientist's dream 2First-ever blueprint of a minimal cell is more complex than expected 2First-ever blueprint of a minimal cell is more complex than expected 3Researchers discover biological basis of 'bacterial immune system' 2Researchers discover biological basis of 'bacterial immune system' 3Cholesterol and Cancer 3A Answers and Some New Questions 60688 1Cholesterol and Cancer 3A Answers and Some New Questions 60688 2Cholesterol and Cancer 3A Answers and Some New Questions 60688 3Cholesterol and Cancer 3A Answers and Some New Questions 60688 4Cholesterol and Cancer 3A Answers and Some New Questions 60688 5Whistleblower Lawsuit Nets Record 2427 5 Million 60685 1Whistleblower Lawsuit Nets Record 2427 5 Million 60685 2Whistleblower Lawsuit Nets Record 2427 5 Million 60685 3BibsToGo com Answers 3A How Can a Traditional Baby Product Help Corporate America Look Better 3F 60682 1BibsToGo com Answers 3A How Can a Traditional Baby Product Help Corporate America Look Better 3F 60682 2
...University and Texas A & M University have discove...n to specific tissues in animals. In studies to d...ding cells, the group previously identified a regi...was able to mediate nuclear targeting of any plasm...oth muscle cells but in no other cell type. In th...
...at an FDA-approved drug reverses the brain dysfunc...s sclerosis complex (TSC). Because half of TSC pa... new hope for addressing learning disorders due to... in its online June 22 edition. , Using a mouse m...rug approved by the FDA to fight tissue rejection ...
... Webinar hosted by TorreyPines Therapeutics, Inc. ...g together industry experts to discuss the opport...e spasticity through the inhibition of the neurotr...d Chief Executive Officer, Neil Kurtz, M.D., will ...s by: , Tony Yaksh, Ph.D., Professor and Vice C...
Other Biology News:New paradigm for cell-specific gene delivery 2Drug reverses mental retardation caused by genetic disorder 2Treating chronic pain, migraine & muscle spasticity through inhibition of neurotransmitter glutamate 2Treating chronic pain, migraine & muscle spasticity through inhibition of neurotransmitter glutamate 3
(Date:11/30/2009)...nternational team of applied scientists from Harva...trated compact, multibeam, and multi-wavelength la...pectrum (infrared). By contrast, typical lasers em...h. The innovative multibeam lasers have potential ...sing pollution monitoring, optical wireless, and i...
(Date:11/30/2009)...v. 30 Good Publication Practice 2 ...n of company-sponsored medical research, has been ...nal (BMJ). "The publication of GPP2 in BMJ is stro...ort and guidance for industry sponsored research a...viewed medical literature," said Chris Graf, Assoc...
(Date:11/30/2009)...re-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nas...g Administration (FDA) has granted orphan drug des...pridine phosphate, for the rare autoimmune disease...P has previously received orphan drug designation ...for Medicinal Products for Human Use of the Europe...
(Date:11/30/2009)... ApaTech, the rapidly growing,orth...wing,Biotech/Pharmaceutical/Medical Technology/Equ...t 500 for EMEA (Europe, Middle East and Africa). ,...ies, five-year revenue growth,for which ApaTech h...s,achievement places ApaTech 9th overall in the ra...
Breaking Biology Technology:Scientists demonstrate multibeam, multi-functional lasers 2ISMPP Announces Publication of Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP2 Guidelines Published in the BMJ 2ISMPP Announces Publication of Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP2 Guidelines Published in the BMJ 3FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 2FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 3FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 4ApaTech is Europe's Fastest Growing Lifescience Company 2ApaTech is Europe's Fastest Growing Lifescience Company 3ApaTech is Europe's Fastest Growing Lifescience Company 4
...ompany Reports Quarterly Net Income of $536,000 , ...l, Inc. (OTC Bulletin Board: CCEL) (the "Company"... family cord blood banks, today announced results ...nsolidated revenues for the first quarter of fisca... approximately $4.2 million for the first quarter ...
... Millennium Bioceutics, announces the...Caplex, to cancer patients worldwide. Caplex con...by an Oncologist and Clinical Dietitian. Caplex n...prehensive source of the most effective anti-tumor...ccumulated from medical research. Impressive chang...
...ina, April 8 Sinobiopharma Pharmaceutical Group (...he appointment of Ms. Yan Tan as Director of Marke...n Pharmaceutical Co., Ltd., Netherlands. She serve...anon, which was recently sold to Schering-Plough. ...nagement roles at China National Medicines Corpora...
Other Biology Technology:Cryo-Cell International, Inc. Reports First Quarter 2009 Results 2Cryo-Cell International, Inc. Reports First Quarter 2009 Results 3Cryo-Cell International, Inc. Reports First Quarter 2009 Results 4Cancer Fighting Nutrition Supplement, Caplex, Offers Cancer Patients A New All-Natural Treatment Option 2Sinobiopharma, Inc. Appoints New Director of Marketing 2
10% Normal Goat Serum from Invitrogen
GeneRacer Kit with SuperScript II RT and Zero Blunt TOPO PCR Cloning kit for Sequencing from Invitrogen
Goat Anti-Mouse Wnt-9b Affinity Purified Polyclonal Antibody, Unconjugated from R&D Systems
Chloride Colorimetric Assay Kit, QuantiChrom from BioAssay Systems
Biology Products: